Geneva Capital Management LLC Sells 265 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Geneva Capital Management LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,698 shares of the medical equipment provider’s stock after selling 265 shares during the quarter. Geneva Capital Management LLC’s holdings in Intuitive Surgical were worth $1,930,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at approximately $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the 4th quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $31,000. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Finally, Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 5.2 %

Shares of ISRG opened at $538.57 on Friday. The firm has a market cap of $191.83 billion, a PE ratio of 84.02, a P/E/G ratio of 5.85 and a beta of 1.43. The firm has a fifty day simple moving average of $571.70 and a two-hundred day simple moving average of $530.95. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on ISRG shares. Stifel Nicolaus boosted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, UBS Group upped their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,090 shares of company stock worth $7,496,119 in the last three months. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.